TELA Bio, Inc. Net Income (Loss) Available to Common Stockholders, Basic
TELA Bio, Inc. (TELA) reported Net Income (Loss) Available to Common Stockholders, Basic of -$33.28 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-23.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2022-03-23
- TELA Bio, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-12-31 was -$7.79M.
- TELA Bio, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-09-30 was -$7.70M.
- TELA Bio, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-06-30 was -$6.08M.
- TELA Bio, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-03-31 was -$7.22M.
- TELA Bio, Inc. net income (loss) available to common stockholders, basic for fiscal 2021 was -$33.28M.
- TELA Bio, Inc. net income (loss) available to common stockholders, basic for fiscal 2020 was -$28.79M.
- TELA Bio, Inc. net income (loss) available to common stockholders, basic for fiscal 2019 was -$30.21M.
- TELA Bio, Inc. net income (loss) available to common stockholders, basic for fiscal 2018 was -$29.91M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$33.28M 10-K · filed 2022-03-23 | |||
| 2020-12-31 | -$7.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$15.49M derived: sum of 2 quarters · filed 2022-03-23 | -$21.57M derived: sum of 3 quarters · filed 2022-03-23 | -$28.79M 10-K · filed 2022-03-23 |
| 2020-09-30 | -$7.70M 10-Q · filed 2020-11-12 | -$13.78M derived: sum of 2 quarters · filed 2020-11-12 | -$21.00M 10-Q · filed 2020-11-12 | -$28.48M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | -$6.08M 10-Q · filed 2020-08-13 | -$13.30M 10-Q · filed 2020-08-13 | -$20.77M derived: sum of 3 quarters · filed 2022-03-23 | -$27.50M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | -$7.22M 10-Q · filed 2020-05-15 | -$14.69M derived: sum of 2 quarters · filed 2022-03-23 | -$21.42M derived: sum of 3 quarters · filed 2022-03-23 | -$29.44M derived: sum of 4 quarters · filed 2022-03-23 |
| 2019-12-31 | -$7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$14.20M derived: sum of 2 quarters · filed 2022-03-23 | -$22.22M derived: sum of 3 quarters · filed 2022-03-23 | -$30.21M 10-K · filed 2022-03-23 |
| 2019-09-30 | -$6.72M 10-Q · filed 2020-11-12 | -$14.75M derived: sum of 2 quarters · filed 2020-11-12 | -$22.74M 10-Q · filed 2020-11-12 | -$32.10M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | -$8.02M 10-Q · filed 2020-08-13 | -$16.01M 10-Q · filed 2020-08-13 | -$25.38M derived: sum of 3 quarters · filed 2021-03-25 | -$30.06M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-03-31 | -$7.99M 10-Q · filed 2020-05-15 | -$17.36M derived: sum of 2 quarters · filed 2021-03-25 | -$22.03M derived: sum of 3 quarters · filed 2021-03-25 | |
| 2018-12-31 | -$9.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$14.04M derived: sum of 2 quarters · filed 2021-03-25 | -$29.91M 10-K · filed 2021-03-25 | |
| 2018-09-30 | -$4.68M 10-Q · filed 2019-12-18 | -$20.55M 10-Q · filed 2019-12-18 | ||
| 2017-12-31 | -$27.23M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |